MUMBAI, India, June 13, 2011 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its U.S. subsidiary, Lupin Pharmaceutical Inc.

ARDEE, Ireland, Sept. 10 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that one of its subsidiaries has filed two lawsuits against Lupin Limited and its wholly owned subsidiary Lupin Pharmaceuticals, Inc.

BALTIMORE, Jan. 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets 250mg, 500mg, 750mg and 1000mg from the U.S. Food and Drug Administration (USFDA).

BALTIMORE, Sept. 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it received the "2008 2nd Quarter recipient of the Award of Excellence" from Wal-Mart Stores, Inc. Commenting on the award, Vinita Gupta, President and Managing Director of Lupin Pharmaceuticals, Inc.

BALTIMORE, July 31 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for Divalproex Sodium Delayed-Release Tablets, 125 mg, 250 mg and 500 mg from the U.S.